世界のモノアミン酸化酵素阻害薬（MAOI）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Monoamine Oxidase Inhibitor (MAOIs) Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3902
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、モノアミン酸化酵素阻害薬（MAOI）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非選択的MAO-A/MAO-B阻害薬、選択的MAO-A/MAO-B阻害薬）、用途別市場規模（非定型うつ病治療、パーキンソン病治療、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・モノアミン酸化酵素阻害薬（MAOI）の市場動向
・企業の競争状況、市場シェア
・モノアミン酸化酵素阻害薬（MAOI）の種類別市場規模（非選択的MAO-A/MAO-B阻害薬、選択的MAO-A/MAO-B阻害薬）
・モノアミン酸化酵素阻害薬（MAOI）の用途別市場規模（非定型うつ病治療、パーキンソン病治療、その他）
・モノアミン酸化酵素阻害薬（MAOI）の北米市場規模2016-2027（アメリカ、カナダ）
・モノアミン酸化酵素阻害薬（MAOI）のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・モノアミン酸化酵素阻害薬（MAOI）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・モノアミン酸化酵素阻害薬（MAOI）の中南米市場規模2016-2027（メキシコ、ブラジル）
・モノアミン酸化酵素阻害薬（MAOI）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis、Pfizer、Validus Pharmaceuticals LLC、Eli Lilly & Company、GlaxoSmithKline、Merck & Co、Concordia Pharms）
・結論

MAOIs are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B). They are widely used as anti-depressants.

Market Analysis and Insights: Global Monoamine Oxidase Inhibitor (MAOIs) Market
The global Monoamine Oxidase Inhibitor (MAOIs) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Monoamine Oxidase Inhibitor (MAOIs) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Monoamine Oxidase Inhibitor (MAOIs) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Monoamine Oxidase Inhibitor (MAOIs) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Monoamine Oxidase Inhibitor (MAOIs) market.

Global Monoamine Oxidase Inhibitor (MAOIs) Scope and Market Size
Monoamine Oxidase Inhibitor (MAOIs) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Monoamine Oxidase Inhibitor (MAOIs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nonselective MAO-A/MAO-B inhibitors
Selective MAO-A/MAO-B inhibitors

Segment by Application
Atypical Depression Treatment
Parkinson’s Disease Treatment
Other Therapy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Pfizer
Validus Pharmaceuticals LLC
Eli Lilly & Company
GlaxoSmithKline

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoamine Oxidase Inhibitor (MAOIs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nonselective MAO-A/MAO-B inhibitors
1.2.3 Selective MAO-A/MAO-B inhibitors
1.3 Market by Application
1.3.1 Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Atypical Depression Treatment
1.3.3 Parkinson’s Disease Treatment
1.3.4 Other Therapy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Monoamine Oxidase Inhibitor (MAOIs) Market Perspective (2016-2027)
2.2 Monoamine Oxidase Inhibitor (MAOIs) Growth Trends by Regions
2.2.1 Monoamine Oxidase Inhibitor (MAOIs) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Monoamine Oxidase Inhibitor (MAOIs) Historic Market Share by Regions (2016-2021)
2.2.3 Monoamine Oxidase Inhibitor (MAOIs) Forecasted Market Size by Regions (2022-2027)
2.3 Monoamine Oxidase Inhibitor (MAOIs) Industry Dynamic
2.3.1 Monoamine Oxidase Inhibitor (MAOIs) Market Trends
2.3.2 Monoamine Oxidase Inhibitor (MAOIs) Market Drivers
2.3.3 Monoamine Oxidase Inhibitor (MAOIs) Market Challenges
2.3.4 Monoamine Oxidase Inhibitor (MAOIs) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Monoamine Oxidase Inhibitor (MAOIs) Players by Revenue
3.1.1 Global Top Monoamine Oxidase Inhibitor (MAOIs) Players by Revenue (2016-2021)
3.1.2 Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Players (2016-2021)
3.2 Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoamine Oxidase Inhibitor (MAOIs) Revenue
3.4 Global Monoamine Oxidase Inhibitor (MAOIs) Market Concentration Ratio
3.4.1 Global Monoamine Oxidase Inhibitor (MAOIs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoamine Oxidase Inhibitor (MAOIs) Revenue in 2020
3.5 Monoamine Oxidase Inhibitor (MAOIs) Key Players Head office and Area Served
3.6 Key Players Monoamine Oxidase Inhibitor (MAOIs) Product Solution and Service
3.7 Date of Enter into Monoamine Oxidase Inhibitor (MAOIs) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Monoamine Oxidase Inhibitor (MAOIs) Breakdown Data by Type
4.1 Global Monoamine Oxidase Inhibitor (MAOIs) Historic Market Size by Type (2016-2021)
4.2 Global Monoamine Oxidase Inhibitor (MAOIs) Forecasted Market Size by Type (2022-2027)

5 Monoamine Oxidase Inhibitor (MAOIs) Breakdown Data by Application
5.1 Global Monoamine Oxidase Inhibitor (MAOIs) Historic Market Size by Application (2016-2021)
5.2 Global Monoamine Oxidase Inhibitor (MAOIs) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size (2016-2027)
6.2 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type
6.2.1 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021)
6.2.2 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2022-2027)
6.2.3 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2027)
6.3 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application
6.3.1 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2021)
6.3.2 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2022-2027)
6.3.3 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2027)
6.4 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country
6.4.1 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2016-2021)
6.4.2 North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size (2016-2027)
7.2 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type
7.2.1 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021)
7.2.2 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2022-2027)
7.2.3 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2027)
7.3 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application
7.3.1 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2021)
7.3.2 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2022-2027)
7.3.3 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2027)
7.4 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country
7.4.1 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2016-2021)
7.4.2 Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size (2016-2027)
8.2 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type
8.2.1 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2027)
8.3 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application
8.3.1 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2027)
8.4 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Region
8.4.1 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size (2016-2027)
9.2 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type
9.2.1 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021)
9.2.2 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2022-2027)
9.2.3 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2027)
9.3 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application
9.3.1 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2021)
9.3.2 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2022-2027)
9.3.3 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2027)
9.4 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country
9.4.1 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2016-2021)
9.4.2 Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size (2016-2027)
10.2 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type
10.2.1 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2027)
10.3 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application
10.3.1 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2027)
10.4 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country
10.4.1 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Monoamine Oxidase Inhibitor (MAOIs) Introduction
11.1.4 Novartis Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Monoamine Oxidase Inhibitor (MAOIs) Introduction
11.2.4 Pfizer Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Validus Pharmaceuticals LLC
11.3.1 Validus Pharmaceuticals LLC Company Details
11.3.2 Validus Pharmaceuticals LLC Business Overview
11.3.3 Validus Pharmaceuticals LLC Monoamine Oxidase Inhibitor (MAOIs) Introduction
11.3.4 Validus Pharmaceuticals LLC Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
11.3.5 Validus Pharmaceuticals LLC Recent Development
11.4 Eli Lilly & Company
11.4.1 Eli Lilly & Company Company Details
11.4.2 Eli Lilly & Company Business Overview
11.4.3 Eli Lilly & Company Monoamine Oxidase Inhibitor (MAOIs) Introduction
11.4.4 Eli Lilly & Company Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
11.4.5 Eli Lilly & Company Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoamine Oxidase Inhibitor (MAOIs) Introduction
11.5.4 GlaxoSmithKline Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Merck & Co
11.6.1 Merck & Co Company Details
11.6.2 Merck & Co Business Overview
11.6.3 Merck & Co Monoamine Oxidase Inhibitor (MAOIs) Introduction
11.6.4 Merck & Co Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
11.6.5 Merck & Co Recent Development
11.7 Concordia Pharms
11.7.1 Concordia Pharms Company Details
11.7.2 Concordia Pharms Business Overview
11.7.3 Concordia Pharms Monoamine Oxidase Inhibitor (MAOIs) Introduction
11.7.4 Concordia Pharms Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
11.7.5 Concordia Pharms Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nonselective MAO-A/MAO-B inhibitors
Table 3. Key Players of Selective MAO-A/MAO-B inhibitors
Table 4. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Regions (2016-2021)
Table 8. Global Monoamine Oxidase Inhibitor (MAOIs) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Regions (2022-2027)
Table 10. Monoamine Oxidase Inhibitor (MAOIs) Market Trends
Table 11. Monoamine Oxidase Inhibitor (MAOIs) Market Drivers
Table 12. Monoamine Oxidase Inhibitor (MAOIs) Market Challenges
Table 13. Monoamine Oxidase Inhibitor (MAOIs) Market Restraints
Table 14. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Players (2016-2021)
Table 16. Global Top Monoamine Oxidase Inhibitor (MAOIs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoamine Oxidase Inhibitor (MAOIs) as of 2020)
Table 17. Ranking of Global Top Monoamine Oxidase Inhibitor (MAOIs) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Monoamine Oxidase Inhibitor (MAOIs) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Monoamine Oxidase Inhibitor (MAOIs) Product Solution and Service
Table 21. Date of Enter into Monoamine Oxidase Inhibitor (MAOIs) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Type (2016-2021)
Table 25. Global Monoamine Oxidase Inhibitor (MAOIs) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Application (2016-2021)
Table 29. Global Monoamine Oxidase Inhibitor (MAOIs) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis Company Details
Table 62. Novartis Business Overview
Table 63. Novartis Monoamine Oxidase Inhibitor (MAOIs) Product
Table 64. Novartis Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Monoamine Oxidase Inhibitor (MAOIs) Product
Table 69. Pfizer Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Validus Pharmaceuticals LLC Company Details
Table 72. Validus Pharmaceuticals LLC Business Overview
Table 73. Validus Pharmaceuticals LLC Monoamine Oxidase Inhibitor (MAOIs) Product
Table 74. Validus Pharmaceuticals LLC Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021) & (US$ Million)
Table 75. Validus Pharmaceuticals LLC Recent Development
Table 76. Eli Lilly & Company Company Details
Table 77. Eli Lilly & Company Business Overview
Table 78. Eli Lilly & Company Monoamine Oxidase Inhibitor (MAOIs) Product
Table 79. Eli Lilly & Company Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021) & (US$ Million)
Table 80. Eli Lilly & Company Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Monoamine Oxidase Inhibitor (MAOIs) Product
Table 84. GlaxoSmithKline Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Merck & Co Company Details
Table 87. Merck & Co Business Overview
Table 88. Merck & Co Monoamine Oxidase Inhibitor (MAOIs) Product
Table 89. Merck & Co Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021) & (US$ Million)
Table 90. Merck & Co Recent Development
Table 91. Concordia Pharms Company Details
Table 92. Concordia Pharms Business Overview
Table 93. Concordia Pharms Monoamine Oxidase Inhibitor (MAOIs) Product
Table 94. Concordia Pharms Revenue in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021) & (US$ Million)
Table 95. Concordia Pharms Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Type: 2020 VS 2027
Figure 2. Nonselective MAO-A/MAO-B inhibitors Features
Figure 3. Selective MAO-A/MAO-B inhibitors Features
Figure 4. Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Application: 2020 VS 2027
Figure 5. Atypical Depression Treatment Case Studies
Figure 6. Parkinson's Disease Treatment Case Studies
Figure 7. Other Therapy Case Studies
Figure 8. Monoamine Oxidase Inhibitor (MAOIs) Report Years Considered
Figure 9. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Monoamine Oxidase Inhibitor (MAOIs) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Regions: 2020 VS 2027
Figure 12. Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Regions (2022-2027)
Figure 13. Global Monoamine Oxidase Inhibitor (MAOIs) Market Share by Players in 2020
Figure 14. Global Top Monoamine Oxidase Inhibitor (MAOIs) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoamine Oxidase Inhibitor (MAOIs) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Monoamine Oxidase Inhibitor (MAOIs) Revenue in 2020
Figure 16. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Type (2016-2021)
Figure 17. Global Monoamine Oxidase Inhibitor (MAOIs) Revenue Market Share by Type (2022-2027)
Figure 18. North America Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Monoamine Oxidase Inhibitor (MAOIs) Market Share by Type (2016-2027)
Figure 20. North America Monoamine Oxidase Inhibitor (MAOIs) Market Share by Application (2016-2027)
Figure 21. North America Monoamine Oxidase Inhibitor (MAOIs) Market Share by Country (2016-2027)
Figure 22. United States Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Monoamine Oxidase Inhibitor (MAOIs) Market Share by Type (2016-2027)
Figure 26. Europe Monoamine Oxidase Inhibitor (MAOIs) Market Share by Application (2016-2027)
Figure 27. Europe Monoamine Oxidase Inhibitor (MAOIs) Market Share by Country (2016-2027)
Figure 28. Germany Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Monoamine Oxidase Inhibitor (MAOIs) Market Share by Region (2016-2027)
Figure 38. China Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Share by Type (2016-2027)
Figure 46. Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Share by Application (2016-2027)
Figure 47. Latin America Monoamine Oxidase Inhibitor (MAOIs) Market Share by Country (2016-2027)
Figure 48. Mexico Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Monoamine Oxidase Inhibitor (MAOIs) Market Share by Country (2016-2027)
Figure 54. Turkey Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Monoamine Oxidase Inhibitor (MAOIs) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Novartis Revenue Growth Rate in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
Figure 59. Validus Pharmaceuticals LLC Revenue Growth Rate in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
Figure 60. Eli Lilly & Company Revenue Growth Rate in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
Figure 62. Merck & Co Revenue Growth Rate in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
Figure 63. Concordia Pharms Revenue Growth Rate in Monoamine Oxidase Inhibitor (MAOIs) Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Global Reversible Inhibitors of Monoamine (RIMA) Antidepressants Market Size, Status and Forecast 2021-2027
QYR2104Z5033 2021年4月 94Pages
QYResearch社発行の本調査資料では、可逆性モノアミン系抗うつ阻害剤（RIMA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非選択MAO-阻害剤、選択MAO-B阻害剤、非選択MAO-B阻害剤）、用途別市場規模（うつ病治療、パーキンソン...

世界の血漿プロテアーゼC1阻害剤治療市場規模・現状・予測（2021年-2027年）

Global Plasma Protease C1-inhibitor Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4640 2021年4月 94Pages
QYResearch社発行の本調査資料では、血漿プロテアーゼC1阻害剤治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（C1阻害剤、カリクレイン阻害剤（カルビトール））、用途別市場規模（病院薬局、独立型薬局＆アウトレット）、主要地域別市場規模...

世界のPARP阻害剤バイオマーカーサービス市場規模・現状・予測（2021年-2027年）

Global PARP Inhibitor Biomarkers Service Market Size, Status and Forecast 2021-2027
QYR2104Z4445 2021年4月 96Pages
QYResearch社発行の本調査資料では、PARP阻害剤バイオマーカーサービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（BRCA 1＆2検査、HRD検査、HRR検査、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（...

世界のVEGF/VEGFR阻害薬市場規模・現状・予測（2021年-2027年）

Global VEGF/VEGFR Inhibitor Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z5872 2021年4月 92Pages
QYResearch社発行の本調査資料では、VEGF/VEGFR阻害薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（チロシンキナーゼ阻害剤、モノクローナル抗体、その他）、用途別市場規模（腫瘍学、眼科、その他）、主要地域別市場規模（北米、アメリ...

世界のサイクリン依存性キナーゼ阻害剤市場規模・現状・予測（2021年-2027年）

Global Cyclin Dependent Kinase Inhibitor Market Size, Status and Forecast 2021-2027
QYR2104Z1695 2021年4月 95Pages
QYResearch社発行の本調査資料では、サイクリン依存性キナーゼ阻害剤のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（広範囲用CDK阻害剤、特定用CDK阻害剤）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ...

世界のアデノシンデアミナーゼ欠損症（ADA）市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Market Size, Status and Forecast 2021-2027
QYR2104Z0094 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本...

世界のチャネルインアボックス（CiaB）市場規模・現状・予測（2021年-2027年）

Global Channel-in-a-Box Market Size, Status and Forecast 2021-2027
QYR2104Z1255 2021年4月 94Pages
QYResearch社発行の本調査資料では、チャネルインアボックス（CiaB）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ソフトウェア、ハードウェア）、用途別市場規模（住宅用、商業用、公共・政府インフラストラクチャ）、主要地域別市場規模（...

世界の癌胎児性抗原（CEA）市場規模・現状・予測（2021年-2027年）

Global Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2021-2027
QYR2104Z1106 2021年4月 90Pages
QYResearch社発行の本調査資料では、癌胎児性抗原（CEA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CD66a、CD66b、CD66c、CD66d、CD66e、CD66f）、用途別市場規模（大腸がん、膵臓がん、卵巣がん、乳がん、甲...

世界のエキシマレーザアニール装置（ELA）市場規模・現状・予測（2021年-2027年）

Global Excimer Laser Annealing (ELA) Market Size, Status and Forecast 2021-2027
QYR2104Z2268 2021年4月 94Pages
QYResearch社発行の本調査資料では、エキシマレーザアニール装置（ELA）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（XeCl（308nm）ELA、KrF（248nm）ELA）、用途別市場規模（工業、実験室、その他）、主要地域別市場規...

世界のインフィニバンド（InfiniBand）市場規模・現状・予測（2021年-2027年）

Global InfiniBand Market Size, Status and Forecast 2021-2027
QYR2104Z3157 2021年4月 98Pages
QYResearch社発行の本調査資料では、インフィニバンド（InfiniBand）のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シングルデータレート、ダブルデータレート、クワッドデータレート、14データレート、拡張データレート）、用途別市場...

世界の可逆性モノアミン系抗うつ阻害剤（RIMA）市場規模・現状・予測（2021年-2027年） RIMAs are used as antidepressants. They work by reducing the activity of monoamine oxidase which is a chemical found throughout the body. Monoamine oxidase breaks down noradrenaline (also called norepinephrine) and serotonin and other chemicals made and used by the body and brain. These chemicals ar…
世界の血漿プロテアーゼC1阻害剤治療市場規模・現状・予測（2021年-2027年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…
世界の産後うつ病治療薬市場規模・現状・予測（2021年-2027年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
世界の産後うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
世界の産後うつ病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Postpartum Depression Treatment Market The global Postpartum Depression Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…